FDA Accepts Final Protocol for Pivotal Phase 3 Alzheimer’s Disease Study, Streamlining Development Pathway
Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative ...
Dr Michael Mosley's 2p pill could help protect against dementia
According to Alzheimer's Society, around 982,000 people are living with dementia in the UK - this is expected to increase to 1.4 million by 2040 ...